Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.5098
-0.0095 (-1.82%)
Jul 11, 2025, 2:42 PM EDT

Elite Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
556465157293562
Upgrade
Market Cap Growth
195.83%195.83%434.24%-16.81%-42.59%1.75%
Upgrade
Enterprise Value
556468159273161
Upgrade
Last Close Price
0.520.430.150.030.030.06
Upgrade
PE Ratio
--7.818.263.9712.10
Upgrade
PS Ratio
6.625.532.770.861.102.42
Upgrade
PB Ratio
10.398.682.731.011.403.81
Upgrade
P/TBV Ratio
10.458.732.741.031.433.92
Upgrade
P/FCF Ratio
95.3679.70--5.8821.50
Upgrade
P/OCF Ratio
74.5762.33-8.815.4319.27
Upgrade
EV/Sales Ratio
6.615.562.810.800.962.40
Upgrade
EV/EBITDA Ratio
23.6120.4313.095.254.9417.86
Upgrade
EV/EBIT Ratio
26.2022.0514.756.926.1128.90
Upgrade
EV/FCF Ratio
95.2980.19--5.1521.24
Upgrade
Debt / Equity Ratio
0.200.200.200.130.110.15
Upgrade
Debt / EBITDA Ratio
0.460.460.950.730.430.66
Upgrade
Debt / FCF Ratio
1.871.87--0.460.83
Upgrade
Asset Turnover
0.930.930.910.901.050.99
Upgrade
Inventory Turnover
3.013.012.692.162.972.95
Upgrade
Quick Ratio
3.423.422.041.401.731.15
Upgrade
Current Ratio
4.884.883.072.752.822.10
Upgrade
Return on Equity (ROE)
-7.77%-7.77%46.47%13.15%43.01%37.96%
Upgrade
Return on Assets (ROA)
14.72%14.72%10.83%6.52%10.33%5.14%
Upgrade
Return on Capital (ROIC)
19.82%19.82%13.20%8.15%13.62%7.92%
Upgrade
Return on Capital Employed (ROCE)
25.10%25.10%15.30%12.00%17.80%10.30%
Upgrade
Earnings Yield
-0.78%-0.93%12.80%12.11%25.18%8.27%
Upgrade
FCF Yield
1.05%1.26%-2.57%-8.15%17.00%4.65%
Upgrade
Buyback Yield / Dilution
-4.40%-4.40%-1.02%-0.23%-7.17%5.06%
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.